S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

UNCY Unicycive Therapeutics Inc

0.416

-0.0008 (-0.19%)

Pre Market

Last Updated: 03:23:30

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics Inc News

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Tuesday 24 September 2024 (6 days ago) • GlobeNewswire Inc.

Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024
Monday 16 September 2024 (2 weeks ago) • GlobeNewswire Inc.

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Thursday 5 September 2024 (4 weeks ago) • GlobeNewswire Inc.

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Tuesday 3 September 2024 (4 weeks ago) • GlobeNewswire Inc.

Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024
Monday 26 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
Wednesday 14 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
Wednesday 17 July 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Tuesday 16 July 2024 (2 months ago) • Edgar (US Regulatory)

More Unicycive Therapeutics Inc News Articles

NaturalShrimp (QB)

Anavex Life Sciences

Voip Pal Com (QB)

Baron Capital Enterprise (CE)

Digital Brand Media and ... (PK)

Fannie Mae (QB)

TransCode Therapeutics

Rennova Health (CE)

AMC Entertainment

Lightwave Logic

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions